<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endogenous <z:chebi fb="3" ids="16335">adenosine</z:chebi> released locally during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> is neuroprotective, and agents which decrease <z:chebi fb="3" ids="16335">adenosine</z:chebi> inactivation may potentiate its protective effects </plain></SENT>
<SENT sid="1" pm="."><plain>The effects of 5'-deoxy-5-iodotubercidin (5'd-5IT), an inhibitor of the <z:chebi fb="3" ids="16335">adenosine</z:chebi>-catabolizing enzyme, <z:chebi fb="3" ids="16335">adenosine</z:chebi> kinase, were studied in male Wistar rats subjected to 2 h of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>5'd-5IT or the vehicle (10% DMSO in saline) was administered i.p </plain></SENT>
<SENT sid="3" pm="."><plain>30 min before, and 2 h and 6 h after the induction of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was determine using 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining 48 h after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was significantly reduced in rats treated with 1.85 mg/kg x 3 (57% reduction, P &lt; 0.001) or 1.0 mg/kg x 3 (34% reduction, P &lt; 0.05), but not 0.3 mg/kg x 3 5'd-5IT compared to vehicle-treated rats </plain></SENT>
<SENT sid="6" pm="."><plain>The reduction of <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was accompanied by a significant improvement in behavioral measures of neurological deficit </plain></SENT>
<SENT sid="7" pm="."><plain>These data further support a role of <z:chebi fb="3" ids="16335">adenosine</z:chebi> in neuroprotection and suggest that <z:chebi fb="3" ids="16335">adenosine</z:chebi> kinase inhibition may be a useful approach to the treatment of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>